73 million Americans likely to purchase CBD before year’s end

Print Friendly, PDF & Email
WASHINGTON — The Hemp Business Journal, the hemp division of New Frontier Data, the global authority in data, analytics and business intelligence on the cannabis industry, releases the U.S. Hemp Market Report: Cannabinoids Edition, Volume 1. It is being released ahead of its new free Hemp Cannabinoid Webinar Series, the first in New Frontier Data’s multi-episode hemp webinar seriesIn partnership with Groff North America, a U.S.-based medical grade cannabis ingredient producer, and Farmacy Health, an integrated cannabis health system, the series and report provide an overview of major developments in the North American hemp cannabinoid market.

“Given that more than 3 in 5 Americans believe CBD has valid medical uses, the potential wellness value hemp may provide can no longer go unnoticed,” said New Frontier Data founder and CEO Giadha DeCarcer. “New Frontier Data’s research and analysis indicate the market value of cannabinoids will continue to grow as consumers’ access increases and the therapeutic value of minor cannabinoids such as CBN and CBG are better understood.”

The Hemp Cannabinoid Webinar Series episodes’ topics include:

  • Episode 1: “Risks & Opportunities in the Hemp-Cannabinoid Market”
  • Episode 2: “The Future of Minor Cannabinoids Beyond CBD”
  • Episode 3: “Innovation in CBD Food & Beverage”

Hemp Cannabinoid Series FREE REGISTRATION:https://zoom.us/webinar/register/WN_KI1E54B2RPKpyj85Rga3cQ

U.S. Hemp Market Report: Cannabinoids Edition, Volume 1FREE DOWNLOAD: https://newfrontierdata.com/product/us-hemp-market-report-cannabinoids-edition-volume-1/


Comments are closed.